ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2024

Genetics of Longitudinal Kidney Function in Children and Adults with Systemic Lupus Erythematosus

Thai-Son Tang1, Declan Webber 2, Jingjing Cao 3, Daniela Dominguez 4, Dafna Gladman 5, Andrea Knight 6, Deborah Levy 7, Lawrence Ng 4, Andrew D. Paterson 8, Earl D. Silverman 9, Zahi Touma 10, Murray Urowitz 10, Joan Wither 11, Eleanor M. Pullenayegum 12 and Linda Hiraki 13, 1Dalla Lana School of Public Health, University of Toronto, Toronto, Canada, 2University of Toronto, The Hospital for Sick Children, Toronto, Canada, 3Genetics & Genome Biology, The Hospital for Sick Children, Toronto, Canada, 4Division of Rheumatology, The Hospital for Sick Children, Toronto, Canada, 5Toronto Western Hospital, Toronto, Canada, Toronto, ON, Canada, 6Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 7Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 8Genetics & Genome Biology, The Hospital for Sick Children, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada, 9Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Canada, 10University Health Network, University of Toronto, Toronto, ON, Canada, 11University Health Network, Krembil Research Institute, Toronto, ON, Canada, 12Child Health Evaluative Sciences, The Hospital for Sick Children, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada, 13Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: lupus nephritis and longitudinal studies, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: SLE – Etiology & Pathogenesis Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Genetics influences kidney function (estimated glomerular filtration rate (eGFR)), systemic lupus erythematosus (SLE) and lupus nephritis (LN) risk. Genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) associated with eGFR in the general population as well as SLE. However, few loci have been identified and replicated for LN risk, in part due to heterogeneity with LN. Using quantitative, repeated eGFR measures as opposed to binary LN may be more informative in detecting LN genetic loci. Our objective was to demonstrate repeated eGFR measures as potentially informative measures in GWAS by showing an association exists between SNPs associated with eGFR and SLE on (1) mean and (2) variance of eGFR.

Methods: We included 1167 patients followed in Toronto Lupus Clinics from SickKids and/or the Toronto Western Hospital. Patients met ≥4 ACR and/or SLICC criteria for SLE and were genotyped on the Illumina MEGA or Omni1-Quad arrays. Ungenotyped SNPs were imputed. Non-HLA additive genetic risk scores (GRS) were calculated for SLE, and for eGFR, using published GWAS weights for loci that met p < 5×10-8. LN was confirmed by renal biopsy. Longitudinal, prospectively collected clinical and laboratory data, including serum creatinine, were extracted from lupus databases. eGFR was calculated using the CKD-EPI (≥18y), and Schwartz equations (< 18y). We tested the effect of SLE-GRS and eGFR-GRS with respect to (1) eGFR mean using linear mixed models and (2) eGFR variance through Gamma regression of squared-ordinary least squares jackknife residuals in R. Models included a time-varying indicator for eGFR taken as a child or adult.

Results: Our cohort included 567 (47%) patients with childhood-onset SLE (cSLE) and 615 (53%) adult-onset SLE (aSLE) with a total of 36,258 eGFR measures (23,926 measures (66%) during aSLE). Median follow-up time was 7.52 years [IQR: 3.92, 15.25 years] (Table). The majority were female (87%) and of European ancestry (48%). There was a median lag of 77 days [IQR: 0, 1193 days] between SLE diagnosis and first visit. Under a t-test of independence, we observed lower within-person mean eGFR (p < 0.001) and higher within-person eGFR variance (p < 0.001) in patients with LN compared to those without LN. From linear mixed models and Gamma regression, a unit increase in eGFR-GRS was associated with a 0.60 mL/min/1.73 m2 increase in eGFR (0.60; 95% CI: [0.24, 0.96]; p = 0.001) and a 2% increase in eGFR variance (1.02; 95% CI: [1.02, 1.03]; p < 0.001). A unit increase in SLE-GRS was associated with a 1.28 mL/min/1.73 m2 decrease in eGFR (-1.28; 95% CI: [-2.42, -0.13]; p = 0.029) and a 4% increase in eGFR variance (1.04 95% CI: [1.01, 1.06]; p < 0.001).

Conclusion: Using a large number of repeated eGFR measures taken from people with aSLE and cSLE, we observed that as expected, patients with LN had both lower mean eGFR and higher variability in eGFR, when compared to patients without LN. We demonstrated that eGFR and SLE loci are influencing (1) eGFR mean and (2) eGFR variance in SLE patients. This suggests that longitudinal eGFR measures may be more informative outcomes than binary LN categories for identifying genetics of kidney disease in SLE.

Summary statistics of patient-level laboratory, demographic and clinical characteristics collected during follow-up between LN and non-LN patients.


Disclosure: T. Tang, None; D. Webber, None; J. Cao, None; D. Dominguez, None; D. Gladman, AbbVie, 2, 5, Amgen, 2, 5, BMS, 5, Celgene, 2, 5, Eli Lilly, 2, 5, Galapagos, 5, Galapagos NV, 5, Gilead, 5, GSI, 5, Janssen, 5, Janssen Research & Development, LLC, 2, Novartis, 2, 5, Pfizer, 2, 5, UCB, 2, 5; A. Knight, None; D. Levy, None; L. Ng, None; A. Paterson, None; E. Silverman, None; Z. Touma, Janssen Research & Development, LLC, 2, Janssen Scientific Affairs, LLC, 2; M. Urowitz, Janssen Research & Development, LLC, 2, UCB Pharma, 9; J. Wither, None; E. Pullenayegum, None; L. Hiraki, None.

To cite this abstract in AMA style:

Tang T, Webber D, Cao J, Dominguez D, Gladman D, Knight A, Levy D, Ng L, Paterson A, Silverman E, Touma Z, Urowitz M, Wither J, Pullenayegum E, Hiraki L. Genetics of Longitudinal Kidney Function in Children and Adults with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/genetics-of-longitudinal-kidney-function-in-children-and-adults-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetics-of-longitudinal-kidney-function-in-children-and-adults-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology